• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质组范围数据分析揭示与 SARS-CoV-2 感染相关的组织特异性网络。

Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.

机构信息

CAS Key Laboratory of Systems Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Mollecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.

College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

J Mol Cell Biol. 2020 Jun 11;12(12):946-957. doi: 10.1093/jmcb/mjaa033.

DOI:10.1093/jmcb/mjaa033
PMID:32642770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454804/
Abstract

For patients with COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the damages to multiple organs have been clinically observed. Since most of current investigations for virus-host interaction are based on cell level, there is an urgent demand to probe tissue-specific features associated with SARS-CoV-2 infection. Based on collected proteomic datasets from human lung, colon, kidney, liver, and heart, we constructed a virus-receptor network, a virus-interaction network, and a virus-perturbation network. In the tissue-specific networks associated with virus-host crosstalk, both common and different key hubs are revealed in diverse tissues. Ubiquitous hubs in multiple tissues such as BRD4 and RIPK1 would be promising drug targets to rescue multi-organ injury and deal with inflammation. Certain tissue-unique hubs such as REEP5 might mediate specific olfactory dysfunction. The present analysis implies that SARS-CoV-2 could affect multi-targets in diverse host tissues, and the treatment of COVID-19 would be a complex task.

摘要

对于由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的 COVID-19 患者,已经在临床上观察到多个器官的损伤。由于目前大多数病毒-宿主相互作用的研究都是基于细胞水平,因此迫切需要探测与 SARS-CoV-2 感染相关的组织特异性特征。基于从人肺、结肠、肾、肝和心脏收集的蛋白质组学数据集,我们构建了病毒-受体网络、病毒-相互作用网络和病毒-扰动网络。在与病毒-宿主串扰相关的组织特异性网络中,在不同的组织中揭示了共同和不同的关键枢纽。BRD4 和 RIPK1 等在多种组织中普遍存在的枢纽可能是有希望的药物靶点,可用于挽救多器官损伤和应对炎症。REEP5 等某些组织特有的枢纽可能介导特定的嗅觉功能障碍。本分析表明,SARS-CoV-2 可能会影响多种宿主组织中的多个靶标,而 COVID-19 的治疗将是一项复杂的任务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/cf541113c91d/mjaa033f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/289cfdc0c0d2/mjaa033f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/89d8c9e38876/mjaa033f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/01b4c0860254/mjaa033f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/21083db325a0/mjaa033f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/cf541113c91d/mjaa033f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/289cfdc0c0d2/mjaa033f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/89d8c9e38876/mjaa033f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/01b4c0860254/mjaa033f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/21083db325a0/mjaa033f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e74/7948070/cf541113c91d/mjaa033f5.jpg

相似文献

1
Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.蛋白质组范围数据分析揭示与 SARS-CoV-2 感染相关的组织特异性网络。
J Mol Cell Biol. 2020 Jun 11;12(12):946-957. doi: 10.1093/jmcb/mjaa033.
2
Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.严重 COVID-19 模型中对 SARS-CoV-2 感染反应的动力学多组学分析。
J Virol. 2021 Sep 27;95(20):e0101021. doi: 10.1128/JVI.01010-21. Epub 2021 Jul 28.
3
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.多水平蛋白质组学揭示 SARS-CoV-2 和 SARS-CoV 对宿主的干扰。
Nature. 2021 Jun;594(7862):246-252. doi: 10.1038/s41586-021-03493-4. Epub 2021 Apr 12.
4
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.寻找与 COVID-19 相关的途径:通过 SARS-CoV-2-宿主相互作用组确认发病机制。
Cell Death Dis. 2021 Aug 12;12(8):788. doi: 10.1038/s41419-021-03881-8.
5
Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.基因组尺度差异通量分析揭示了 SARS-CoV-2 感染对肺细胞代谢的调控失调。
PLoS Comput Biol. 2021 Apr 9;17(4):e1008860. doi: 10.1371/journal.pcbi.1008860. eCollection 2021 Apr.
6
Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.基于质谱的蛋白质组学平台,有助于更好地了解 SARS-CoV-2 诱导的发病机制和潜在的诊断方法。
Proteomics. 2021 May;21(10):e2000279. doi: 10.1002/pmic.202000279. Epub 2021 May 5.
7
Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2.基于整数线性规划的病毒-宿主蛋白-蛋白相互作用网络对齐:SARS-CoV-2。
PLoS One. 2020 Dec 7;15(12):e0236304. doi: 10.1371/journal.pone.0236304. eCollection 2020.
8
SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.SARS-CoV-2/人类相互作用组揭示 ACE2 基因座与宿主免疫调节网络的串扰。
Pathog Dis. 2021 Feb 19;79(2). doi: 10.1093/femspd/ftab005.
9
Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.新冠病毒(SARS-CoV-2)与皮肤细胞受体的潜在相互作用:为了解与其他组织相比皮肤损伤频率较低的谜团。
Exp Dermatol. 2020 Oct;29(10):936-944. doi: 10.1111/exd.14186.
10
Host proviral and antiviral factors for SARS-CoV-2.宿主内有利于 SARS-CoV-2 的病毒前体和抗病毒因子。
Virus Genes. 2021 Dec;57(6):475-488. doi: 10.1007/s11262-021-01869-2. Epub 2021 Sep 11.

引用本文的文献

1
In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells.体外分析表明,SARS-CoV-2 感染可使结直肠和前列腺癌细胞中的类似癌症表型和细胞因子表达发生差异调节。
Sci Rep. 2024 Oct 19;14(1):24625. doi: 10.1038/s41598-024-75718-1.
2
Proteomic analysis of lung responses to SARS-CoV-2 infection in aged non-human primates: clinical and research relevance.衰老非人灵长类动物肺部对 SARS-CoV-2 感染反应的蛋白质组学分析:临床和研究相关性。
Geroscience. 2024 Dec;46(6):6395-6417. doi: 10.1007/s11357-024-01264-3. Epub 2024 Jul 6.
3

本文引用的文献

1
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.SARS-CoV-2 感染宿主细胞的蛋白质组学研究揭示了治疗靶点。
Nature. 2020 Jul;583(7816):469-472. doi: 10.1038/s41586-020-2332-7. Epub 2020 May 14.
2
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
3
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID.
从细胞到症状:SARS-CoV-2 致细胞病变效应在 COVID-19 和长新冠发病机制中的作用。
Int J Mol Sci. 2023 May 5;24(9):8290. doi: 10.3390/ijms24098290.
4
Circulating Peptidome Is Strongly Altered in COVID-19 Patients.循环肽组在 COVID-19 患者中发生明显改变。
Int J Environ Res Public Health. 2023 Jan 14;20(2):1564. doi: 10.3390/ijerph20021564.
5
Tissue- and cell-expression of druggable host proteins provide insights into repurposing drugs for COVID-19.药物靶点宿主蛋白的组织和细胞表达为重新利用药物治疗 COVID-19 提供了思路。
Clin Transl Sci. 2022 Dec;15(12):2796-2811. doi: 10.1111/cts.13400. Epub 2022 Oct 19.
6
Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods.蛋白质组学对 SARS-CoV-2 感染机制、诊断、治疗和预后监测方法的研究进展。
Front Immunol. 2022 Sep 20;13:923387. doi: 10.3389/fimmu.2022.923387. eCollection 2022.
7
SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples.SARS-CoV-2 阳性患者的尿液、鼻咽、漱口液和支气管肺泡灌洗液样本中的蛋白质组多样性存在显著差异。
PLoS One. 2022 Aug 8;17(8):e0271870. doi: 10.1371/journal.pone.0271870. eCollection 2022.
8
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.细胞死亡:在 COVID-19 发病机制和干预治疗中的作用。
Signal Transduct Target Ther. 2022 Jun 13;7(1):186. doi: 10.1038/s41392-022-01043-6.
9
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.治疗靶点:SARS-CoV-2 感染诱导的细胞死亡。
Front Immunol. 2022 May 17;13:870216. doi: 10.3389/fimmu.2022.870216. eCollection 2022.
10
Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.网络对网络的概念为宿主- SARS-CoV-2 蛋白相互作用和开发抗病毒药物的潜在新靶点提供了新的见解。
Comput Biol Med. 2022 Jul;146:105575. doi: 10.1016/j.compbiomed.2022.105575. Epub 2022 Apr 30.
严重急性呼吸综合征冠状病毒2感染患者的自我报告嗅觉和味觉障碍:一项横断面研究。
Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.
4
Comorbidities and multi-organ injuries in the treatment of COVID-19.新型冠状病毒肺炎治疗中的合并症与多器官损伤
Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.
5
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
6
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
8
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的综合蛋白质基因组特征分析。
Cell. 2019 Oct 31;179(4):964-983.e31. doi: 10.1016/j.cell.2019.10.007.
9
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.HBV 相关肝细胞癌的综合蛋白质基因组特征分析。
Cell. 2019 Oct 3;179(2):561-577.e22. doi: 10.1016/j.cell.2019.08.052.
10
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.人类结肠癌的蛋白质基因组分析揭示了新的治疗机会。
Cell. 2019 May 2;177(4):1035-1049.e19. doi: 10.1016/j.cell.2019.03.030. Epub 2019 Apr 25.